FDA Food and Drug Administration

Order byBest matchMost fresh

FDA panel is split on updates to COVID shots

FDA picks a new strain for fall Covid vaccines. Here's what it means for your next shot.

The FDA picked the LP.8.1 Covid strain for the fall vaccines, fueling concerns that the shots may be limited to only the most at-risk Americans this fall.

· 2h · on MSN

STAT · 3h

FDA gives Covid vaccine manufacturers instructions for next fall’s shot

· 22h · on MSN

FDA panel is split on updates to COVID shots as questions loom for fall vaccinations

The FDA plans to limit access to covid vaccines. Here’s why that’s not all bad.

Covid vaccines will soon be required to go through more rigorous trials to ensure that they really are beneficial for people who aren’t at high risk.

MIT Technology Review · 10h

· 5h

Here's what to know about the FDA's COVID-19 vaccine changes

· 1d

FDA limits access to COVID-19 vaccine to older adults and other high-risk groups – a public health expert explains the new rules

US FDA Advisers to Weigh Composition of COVID Vaccines for 2025-2026

Public health experts say that there is no certainty on which strains are going to be dominant.

· 1d

· 4h

COVID shots should target newer strains of JN.1 variant, US FDA advisers say

· 21h

With vaccine approval process set to change, FDA advisers leave wiggle room in annual Covid-19 shot recommendations

24mon MSN

FDA warns of severe itching risk when stopping long-term use of allergy medications cetirizine and levocetirizine, affecting quality of life for some users.

FDA Halts Sale of Off-Brand Ozempic and Other GLP-1 Drugs

The U.S. Food and Drug Administration (FDA) already declared that shortages of popular GLP-1 medications have ended, CNN reported. Those medications include semaglutide (Ozempic and Wegovy) and tirzepatide (Mounjaro and Zepbound).

3hon MSN

GSK's asthma drug wins FDA approval to treat 'smoker's lung'

The U.S. Food and Drug Administration has approved British drugmaker GSK's asthma drug to treat some patients with a chronic lung disease commonly known as "smoker's lung", the company said on Thursday.

Nearly 2 million illegal e-cigarettes from China seized by FDA and CBP in joint operation

A joint operation conducted by the Food and Drug Administration and Customs and Border Protection resulted in the seizure of nearly 2 million illegal electronic cigarettes, most of which came from China .

WCPO 9 News1h

Stopping these popular allergy medications could lead to severe itching, FDA warns

People who regularly use the allergy medications Zyrtec or Xyzal may experience severe itching when they stop, the U.S. Food and Drug Administration said in a new warning.

17m

U.S. FDA warns about rare side effect from some allergy drugs

As pollen peaks for the season, the U.S. Food and Drug Administration (FDA) is warning that some popular allergy medications could cause a rare but severe itching side effect.

20hon MSN

Trump's FDA Has Axed COVID Boosters For Most People — And Medical Experts Are Deeply Worried

The vaccine eligibility change is a threat to the health of Americans, some experts say, adding that the FDA is not being forthcoming about its research.

STAT1d

FDA chief pushes back on senators’ criticism, says Covid booster trials should take ‘roughly a year’

The hearing was supposed to focus on the Trump administration’s 2026 budget request, but instead covered a wide range of other FDA issues currently in the political spotlight. The FDA’s budget was not mentioned in the president’s preliminary spending package,

Trump FDA Reveals Canada Will Play Major Role In Bringing Drug Prices Down

The Food and Drug Administration (FDA) announced Wednesday plans to help states and Indian tribes import cheaper prescription drugs from Canada. The initiative is in support of President Donald Trump’s executive order on May 12 which promised to deliver “most-favored nation prescription drug pricing” to America,

1don MSN

Trump administration proposes cutting Food and Drug Administration budget by 5.5%

The Trump administration is proposing a $6.8 billion budget request for the U.S. Food and Drug Administration for the 2026 fiscal year, its Commissioner Martin Makary said on Thursday, a cut of around 5.